Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of July 7, 2026, BCTX trades at $3.49 with a market cap of $28.36M and a P/E ratio of -0.06. BCTX moved +0.29% today. Year to date, BCTX is -53.89%; over the trailing twelve months it is -87.97%. Its 52-week range spans $2.60 to $190.50. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BCTX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.49 |
| Market Cap | $28.36M |
| P/E Ratio | -0.06 |
| EPS | $-62.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $190.50 |
| 52-Week Low | $2.60 |
| Volume | 18.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.56M |
| Gross Margin | 0.00% |
BCTX analyst coverage data. Average price target: $0.00.